All Stories

  1. The adverse outcomes and progressive nature of early-onset colorectal cancer
  2. Overlapping symptoms of pelvic metastasis and degenerative spine disease in colorectal cancer: a challenge in early diagnosis
  3. Solitary Brain Metastasis from Early-Onset Colorectal Cancer, Transient Response to Emergency Radiotherapy: A Rare Case Report
  4. Human Epidermal Growth Factor Receptor 2 Negative, Low, and Overexpression in Breast Cancer Patients: Study on Recurrence-Free and Overall Survival
  5. A progressive disease of bone metastasis in colorectal cancer: Basic consideration
  6. The relationship between KRAS gene mutations in colorectal cancer patients and the response to chemotherapy with a 5-fluorouracil and oxaliplatin regimen at Dr. Moewardi General Hospital
  7. Challenging treatment of enterovesical fistula: a scoping review of pros and cons
  8. Correlation between KRAS mutation status and clinical outcomes in colorectal cancer patients: a retrospective cohort study
  9. Multi-Organ Metastasis in Early-Onset Colorectal Cancer: Emerging Patterns, Biological Drivers, and Therapeutic Implications
  10. Delayed Presentation of Metachronous Ascending Colonic Adenocarcinoma in Early-Onset Colorectal Cancer Undergoing Curative Resection
  11. Lung Cancer: The Current and Multimodality Treatment
  12. Successful management of a rare horseshoe perianal fistula using the modified Hanley procedure: a case report
  13. A paradigm shift in the treatment of advanced-stage lung cancer
  14. Early-Onset Colorectal Cancer in Emergency Settings: Age and Stage Profile of Patients Presenting with Bowel Obstruction
  15. An analysis of the current perspective and review regarding bone metastasis in colorectal adenocarcinoma
  16. Asymptomatic Spleen Metastatic of Colorectal Cancer: A Case Report
  17. Gallstone Ileus Managed with One-Stage Laparotomy : A Rare Case Report
  18. Current perspective on the duration of antibiotic usage: Mandibular fracture and the clinical usage of antibiotics
  19. The identification of synchronous and Metachronous bone metastasis in early-onset colorectal cancer: A critical early strategy for diagnosis
  20. IDDF2025-ABS-0243 Sigmoid adenocarcinoma and the unusual respiratory tract metastasis following curative resection
  21. Short-term clinical outcome of early onset colorectal cancer and bone metastasis progression: Evaluation of zoledronic acid effectivity in controlling the skeletal related events
  22. Evaluating Progesterone Level Fluctuations as a Response Indicator to Chemotherapy in Triple Negative Breast Cancer
  23. Comparison of Disease-Free Survival in Patients with Locally Advanced Early-Onset Colorectal Cancer: 3 vs 6 Months of Adjuvant Chemotherapy
  24. Comparison of Postoperative Outcomes in Colorectal Cancer Patients Undergoing Enhanced Recovery After Surgery (ERAS) vs Non-ERAS: A Retrospective Study
  25. The Efficacy of NeuroAid™ (MLC601) in Modulating NF-κB Expression and Improving Outcomes in Traumatic Brain Injury: A Preclinical Study
  26. Perioperative Blood Glucose Levels as a Predictor of Hospital Length of Stay in Complicated Appendicitis: A Prospective Cohort Study
  27. The Role of Mount Lawu Propolis in Modulating Oxidative Stress and Angiogenic Factors During the Proliferation Phase of Wound Healing
  28. Successful Surgical Management of Partial Obstructive Ileus Secondary to Intra-abdominal Tumor: A Case Report
  29. Asymptomatic Spleen Metastatic of Colorectal Cancer: An Unexpected Finding Following Adjuvant Treatment of Resectable Cases
  30. Propolis from Mount Lawu: Dose-Dependent Antioxidant and Anti-Inflammatory Effects in a Rat Model of Wound Healing
  31. Kualitas Hidup Pasien Kanker Kolorektal dengan Stoma Temporer di RSUD Dr. Moewardi Surakarta
  32. Correlation between smoking behaviour and surgical site infection on grade III colorectal cancer patients following elective colectomy
  33. Rising Trends in Early-Onset Colorectal Cancer: Epidemiological Insights and Future Directions in Multimodal Treatment and Prevention
  34. Analysis of uric acid levels, age, and gender as risk factors for kidney stones
  35. IDDF2024-ABS-0069 The rising incidence of the locally advanced stage of early onset colorectal adenocarcinoma
  36. Effectiveness of Mechanical Treatments (Periosteal Stripping VS Non-Periosteal Stripping) on Fracture Healing: In Vivo Study
  37. Post operative pancreatic fistula associated with failure to rescue on pancreatic cancer undergoing pancreatic resection: a single centre experience
  38. Interrelation between body mass index and the occurrence of gallstones
  39. Renal calculi: The current concept
  40. Surgical site infections: a cross-sectional study of bile culture
  41. Autologous natural killer cells as a promising immunotherapy for locally advanced colon adenocarcinoma: Three years follow‐up of resectable case
  42. The role of feeding jejunostomy on supportive enteral nutrition for resectable esofago-gastric junction adeno carcinoma undergoing total gastrectomy and esofago jejunostomy reconstruction: a case series
  43. Lessons from the COVID-19 Pandemic: A New Paradigm in Treating Patients with Colorectal Cancer
  44. IDDF2022-ABS-0092 The feasibility of modified haemorrhoid artery ligation – recto anal repair (HAL-RAR) with no doppler guided technique on grade iii of internal haemorrhoid disease
  45. IDDF2022-ABS-0093 The role of enhanced recovery after surgery (ERAS) protocol on resectable gastrointestinal cancer during COVID-19 pandemic crisis: a prospective study during pandemic
  46. Procalcitonin (PCT) level as a biomarker of post operative complication after major gastrointestinal Surgery: Comparable or better than c-reactive protein (CRP)
  47. Spontaneous Couniaud Segmen V Hepatic Haemorrhage from Hepatic Cirrhosis: A Rare Clinical Complication and Post Operative Evalution
  48. Relationship between 25(OH)D and Colorectal Cancer Prevalence at Dr. Moewardi Hospital Surakarta-Indonesia: A Cross-Sectional Study
  49. Moist Exposed Burn Ointment Effectiveness for Capecitabine Associated Grade II and III Hand Foot Syndrome on Stage III Colonic
  50. IDDF2021-ABS-0023 Effectivity of moist exposed burn ointment (MEBO) and the role on reducing the chemotherapy interruption of capecitabine associated hand foot syndrome on stage iii colorectal adenocarcinoma
  51. IDDF2021-ABS-0027 Post operative pneumonia after abdominal surgery and the role on unfavorable outcome: evaluation on emergency abdominal surgery patients with COVID-19
  52. Describing the Role of Personal Hygiene on Non-Complicated Pediatric Appendicitis Patients
  53. A rare clinical presentation of third part duodenal perforation due to post‐endoscopic retrograde cholangiopancreatography stent migration on advanced stage peri‐ampullary tumor
  54. Case report: Transformation of juvenile fibroadenoma to borderline phyllodes tumor in young lady
  55. P-32 SARS-CoV-2 pandemic and delayed presentation of gastrointestinal cancer patients: A retrospective evaluation and the impact on clinical outcome
  56. Bismuth Classification of Bile Duct Injury and Its Association with Increasing 30 Days Mortality after Revision Surgery
  57. Predictor factor for inpatients mortality of peptic ulcer emergency surgery during COVID-19 pandemic
  58. Profile of Patients with Gaster Perforation at Dr. Moewardi General Hospital Surakarta in The Period of January-December 2018
  59. Profile of Patients with Gaster Perforation at Dr. Moewardi General Hospital Surakarta in The Period of January-December 2018
  60. Safety and Effectiveness of HAL-RAR (Haemorrhoid Arteri Ligation with Recto Anal Repair) With No Doppler Guided Technique on Stage III Internal Haemorrhoid: A Single Operator Experience
  61. 534 Better immune profiles on elderly colorectal cancer patients correlated with 1 year diseases free survival (DFS)
  62. IDDF2020-ABS-0083 The length of stay difference between open conventional vs laparoscopy cholecystectomy on calculous cholecystitis patients in the current government insurance era
  63. IDDF2020-ABS-0144 Catastrophic emergency events of complicated ulcerative colitis: an impact on clinical outcome
  64. IDDF2020-ABS-0082 Light weight prolene mesh was associated with lower incidence of mesh rejection on inguinal hernia undergoing open emergency hernia surgery
  65. 111P A meta-analysis study on safety and effectiveness comparison between FOLFOX and XELOX regiments on advanced stage colorectal cancer
  66. 328P Impact of COVID-19 pandemic on 30 days colorectal cancer patients mortality undergoing emergency operation
  67. Abstract PO-080: Increasing of emergency presentation on colorectal cancer patients during COVID-19 pandemic: A retrospective study on single-center academic hospital
  68. Methylene Blue Absorption in Sentinel Lymph Node Biopsy for Early Breast Cancer after Neoadjuvant Chemotherapy
  69. Fast Track Protocol for Early Intraabdominal Drain Removal After Colorectal Cancer Surgery Was Not Associated With Surgical Site Infection and Readmission Rate
  70. The immune profiles in young, adult and elderly of advanced stage colorectal cancer patients
  71. IDDF2019-ABS-0060 The difference between brusein-d ligand from makassar ethanolic Fraction (Brucea javanica (L.) Merr) and gemcitabine on the inhibition of panc-1 pancreas carcinoma growth and mutant p53 expression
  72. IDDF2019-ABS-0214 Pain reduction in lichtenstein open inguinal hernia repair using light weight prolene mesh graft on unilateral groin hernia
  73. Segment V spontaneous hepatic haemorrhage from hepatic cirrhosis: an emergency abdominal surgery case report
  74. Gastrointestinal related symptoms on FOLFIRI regiments in resectable stage III colorectal cancer patients: A retrospective study
  75. Early oral intake for unresectable pancreatic cancer patient after palliative surgery: Is that safe for patients?
  76. IDDF2018-ABS-0119 Comparison of fluoroquinolone injection effect for 3 days continued with oral consumption for 4 days, with 7 days injection to wound healing of complicated appendicitis surgery
  77. The role of personal hygiene on non complicated pediatric appendicitis patients
  78. The Role of Deleted in Colorectal Cancer (Dcc) and P53 Mrna Expression In Young Colorectal Cancer Patients
  79. One Year Survival of Resectable Pancreatic Adenocarcinoma in Low Volume Centre Teaching Hospital
  80. Ekspresi Protein Deleted in Colorectal Cancer (DCC) dan p53 pada Keganasan Kolorektal
  81. Korelasi Ekspresi Protein Deleted in Colorectal Cancer (DCC) dengan Keganasan Kolorektal Stadium II dan III